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ABSTRACT 
Coronary revascularisation continues to be underused despite evidence that this 
results in poorer outcomes  
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There are wide variations in revascularisation rates throughout the UK which cannot 
be explained by geographical variations in the incidence of coronary artery disease 
(CAD).1–3 In the USA, intervention rates are double those in the UK.4 Nonetheless, it 
has been suggested that coronary revascularisation rates may be insufficient in some 
areas of the USA.5,6 Under provision of revascularisation in some areas may be 
responsible for preventable morbidity and mortality,7 and inequalities in health. Low 
rates are a result of poorer access to angiography and specialist services within 
some areas.8 In the UK, attempts are being made to address this through the 
appointment of more cardiologists.  
The ACRE (appropriateness of coronary revascularisation) study used the Delphi 
method to define, in detail, the criteria by which patients should be selected for 
coronary angiography and subsequent revascularisation.9 This is a validated and 
widely used method for achieving multidisciplinary consensus.10 The principal 
advantage of the Delphi method, over other consensus methods, is that the panel of 
experts are polled individually and anonymously, thereby assuring that equal weight 
is given to all participants. It has been used previously in a number of other 
countries,11–13 as well as the UK,14 to agree selection criteria for coronary 
interventions. Delphi panel results should only be applied in the countries in which 
they are developed since cultural differences may influence interpretation of 
published literature.11 The ACRE study went further than previous studies in 
determining the extent to which Delphi scores were predictive of clinical prognosis.  
The ACRE expert panel consisted of cardiologists, surgeons, general physicians, and 
general practitioners.9 The panel members were presented with more than 900 case 
scenarios, based on possible permutations of clinical and diagnostic information, 
which they scored according to their appropriateness for coronary revascularisation. 
The results of the consensus process were then applied to a prospective cohort of 
patients who underwent coronary angiography.7 The appropriate management of 
these patients, as defined by the Delphi method, was compared with their actual 
management and their clinical outcome. The Delphi score was predictive of adverse 
clinical outcome, with evidence of a dose effect between the coronary artery bypass 
appropriateness score and subsequent all cause death or myocardial infarction. The 
investigators demonstrated that coronary revascularisation was often not used in 
patients in whom it was judged appropriate. Follow up of these patients suggested 
that failure to use revascularisation where warranted resulted in poorer outcome.  
 
WHO DOES DECIDE? 
 
Following detection of CAD at coronary angiography, a decision must be taken on 
whether to attempt revascularisation, and whether this should be done by coronary 
artery bypass grafting (CABG) or percutaneous coronary intervention (PCI). The 
cardiologist who performs the angiogram may, or may not, perform PCIs. Also, the 
angiogram may be performed in a large teaching hospital which has both PCI and 
CABG on site or in a district general hospital where only PCI or neither service is 
available. These factors should influence neither the likelihood of revascularisation 
being offered nor the type of revascularisation chosen, but they do. There is a large 
body of published evidence demonstrating that patients investigated within a hospital 
where procedures are performed are significantly more likely to undergo the 
procedure than those who require referral from another hospital.3,8,15,16  
A survey which we recently conducted during the Scottish Cardiac Society’s annual 
meeting demonstrated that clinicians’ views of the suitability of a procedure were 
influenced by whether or not they personally performed the procedure, with 
interventional cardiologists preferring PCI to surgery and surgeons preferring surgery 
to PCI.17 This survey demonstrated that discussion between interventional 
cardiologists, non-interventional cardiologists, and surgeons increased consensus on 
the management of patients. But to what extent is multidisciplinary discussion a 
routine part of clinical practice? Traditionally, the cardiologist who performs the 
angiogram has acted as the gatekeeper to revascularisation. In many centres, 
discussion with cardiac surgeons about possible surgery or interventional 
cardiologists about possible PCI takes place only in those patients whom the 
gatekeeper has already decided is suitable for that intervention. Patients screened 
out by the gatekeeper do not benefit from such discussions.  
 
WHO SHOULD DECIDE? 
 
Within cancer services, it is now accepted good practice that elective patient 
management be decided by a multidisciplinary team including surgeons, oncologists, 
and radiotherapists in district general hospitals as well as in tertiary centres.18 Could a 
similar model be adopted for elective coronary revascularisation? At present, 
cardiologists who undertake angiography in tertiary centres have ready access to 
cardiac surgeons and other cardiologists. In some tertiary centres there are formal 
opportunities for discussion through weekly meetings at which cases are discussed 
and management agreed, as well as informal opportunities for discussion in the 
corridor. At present, these opportunities are not available to many cardiologists 
working in district general hospitals. Given the numbers of patients requiring coronary 
angiography and the need to ensure patient access, restricting coronary angiography 
to tertiary centres is not an option.12 Therefore, a mechanism needs to be found to 
ensure that those who work in district general hospitals have regular access to 
cardiac surgeons and, where appropriate, interventional cardiologists. In the future, 
facilities such as tele-medicine and video conferencing may be sufficiently 
widespread within the National Health Service to support virtual meetings. Until then, 
regular face to face meetings are the only solution.  
 
HOW SHOULD THEY DECIDE ? 
 
Multidisciplinary meetings provide a mechanism for ensuring high quality, consistent 
care for those patients managed electively. They are less useful as a vehicle for 
deciding the management of those patients treated as emergencies or those 
undergoing follow on PCIs. However, they may nonetheless improve the care of 
these patients because of their general educational value. Whether clinical decisions 
are taken at multidisciplinary meetings or by individual clinicians, they need to be 
informed by national evidence based guidelines. The Delphi method provides one 
mechanism of collating the results obtained from numerous published studies 
together with clinical experience so that evidence based clinical guidelines and audit 
standards can be produced. However, as with all guidelines, those produced via the 
Delphi method need to be regularly updated as new evidence becomes available. 
The recommendations of the ACRE study already need to be reviewed in light of 
recently published trial results of PCI in patients with multivessel disease.19 It is 
incumbent on those who produce guidelines to ensure that mechanisms are in place 
for reviewing and updating their content.  
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